Acorda Therapeutics Gets OK On $185M Ch. 11 Sale To Merz

By Alex Wittenberg · June 7, 2024, 4:49 PM EDT

Drugmaker Acorda Therapeutics Inc. received a New York bankruptcy judge's approval Friday to complete a $185 million sale of its assets to a fellow pharmaceutical company, allowing Acorda to move ahead...

To view the full article, register now.